10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended September 30, 2012

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 1-33094

AMERICAN CARESOURCE HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

DELAWARE		20-0428568
(State or other jurisdiction of		(I.R.S. employer
incorporation or organization)		identification no.)
	5429 LYNDON B. JOHNSON FREEWAY
	SUITE 850
	DALLAS, TEXAS
	75240
	(Address of principal executive offices)
	(Zip code)

(972) 308-6830

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes xNo o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “accelerated filer”,” large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o	Non-accelerated filer o
Accelerated filer  o (do not check if a smaller reporting company)	Smaller Reporting Company x

Indicated by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.)  Yes o No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:  The number of shares of common stock of registrant outstanding on November 5, 2012 was 5,706,443.

TABLE OF CONTENTS

AMERICAN CARESOURCE HOLDINGS, INC.

FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2012

Part I		Financial Information	1
	Item 1.	Financial Statements	1
		Consolidated Statements of Operations (unaudited)	1
		Consolidated Balance Sheets (unaudited)	2
		Consolidated Statements of Stockholders’ Equity (unaudited)	3
		Consolidated Statements of Cash Flows (unaudited)	4
		Notes to Unaudited Consolidated Financial Statements	5
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	21
	Item 4.	Controls and Procedures	22
Part II		Other Information	23
	Item 1A.	Risk Factors	23
	Item 5.	Other Information	23
	Item 6.	Exhibits	24
		Signatures	25

PART I. FINANCIAL INFORMATION

ITEM 1. Financial Statements

AMERICAN CARESOURCE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(amounts in thousands, except per share data)

	Three months ended September 30,						Nine months ended September 30,
	2012			2011			2012			2011
Net revenues	$	8,186		$	11,496		$	25,802		$	35,881
Cost of revenues:
Provider payments	6,119			9,091			18,992			27,715
Administrative fees	340			616			1,168			1,791
Claims administration and provider development	922			1,067			2,865			3,446
Total cost of revenues	7,381			10,774			23,025			32,952
Contribution margin	805			722			2,777			2,929
Selling, general and administrative expenses	1,654			1,711			4,549			4,726
Goodwill impairment charge	—			4,361			—			4,361
Depreciation and amortization	222			204			662			585
Total operating expenses	1,876			6,276			5,211			9,672
Loss before income taxes	(1,071		)	(5,554		)	(2,434		)	(6,743		)
Income tax provision	4			969			28			647
Net loss	$	(1,075	)	$	(6,523	)	$	(2,462	)	$	(7,390	)
Loss per basic and diluted common share	$	(0.19	)	$	(1.15	)	$	(0.43	)	$	(1.31	)
Basic and diluted weighted average common shares outstanding	5,711			5,670			5,706			5,659

See accompanying notes.

1

AMERICAN CARESOURCE HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

(amounts in thousands except per share amounts)

	September 30, 2012 (Unaudited)			December 31, 2011
ASSETS
Current assets:
Cash and cash equivalents	$	10,295		$	11,315
Accounts receivable, net	2,620			4,317
Prepaid expenses and other current assets	381			559
Deferred income taxes	6			6
Total current assets	13,302			16,197
Property and equipment, net	1,665			1,829
Other assets:
Deferred income taxes	223			226
Other non-current assets	16			16
Intangible assets, net	800			896
	$	16,006		$	19,164
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Due to service providers	$	2,575		$	3,678
Accounts payable and accrued liabilities	1,288			1,237
Total current liabilities	3,863			4,915
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value; 10,000 shares authorized, none issued	—			—
Common stock, $0.01 par value; 40,000 shares authorized; 5,706 and 5,692 shares issued and outstanding in 2012 and 2011, respectively	57			57
Additional paid-in capital	22,770			22,414
Accumulated deficit	(10,684		)	(8,222		)
Total stockholders' equity	12,143			14,249
	$	16,006		$	19,164

See accompanying notes.

2

AMERICAN CARESOURCE HOLDINGS, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

(Unaudited)

(amounts in thousands)

				Additional					Total
	Common Stock			Paid-in		Accumulated			Stockholders'
	Shares	Amount		Capital		Deficit			Equity
Balance at December 31, 2011	5,692	$	57	$	22,414	$	(8,222	)	$	14,249
Net loss	—	—		—		(2,462		)	(2,462		)
Stock-based compensation expense	—	—		333		—			333
Issuance of common stock as equity incentive awards, net of tax withholdings	13	—		23		—			23
Issuance of common stock upon conversion of restricted stock units, net of tax withholdings	1	—		—		—			—
Balance at September 30, 2012	5,706	$	57	$	22,770	$	(10,684	)	$	12,143

See accompanying notes.

3

AMERICAN CARESOURCE HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(amounts in thousands)

	Nine months ended September 30,
	2012			2011
Cash flows from operating activities:
Net loss	$	(2,462	)	$	(7,390	)
Adjustments to reconcile net loss to net cash used in operations:
Non-cash stock-based compensation expense	333			632
Depreciation and amortization	662			585
Goodwill impairment charge	—			4,361
Amortization of long-term client agreement	187			187
Client administration fee expense related to warrants	—			67
Deferred income taxes	3			615
Changes in operating assets and liabilities:
Accounts receivable	1,697			1,730
Prepaid expenses and other assets	—			(81		)
Accounts payable and accrued liabilities	73			76
Due to service providers	(1,103		)	(3,662		)
Net cash used in operating activities	(610		)	(2,880		)
Cash flows from investing activities:
Investment in software development costs	(302		)	(513		)
Additions to property and equipment	(100		)	(58		)
Net cash used in investing activities	(402		)	(571		)
Cash flows from financing activities:
Payment of income tax withholdings on net exercise of equity incentives	(8		)	—
Net cash used in financing activities	(8		)	—
Net decrease in cash and cash equivalents	(1,020		)	(3,451		)
Cash and cash equivalents at beginning of period	11,315			14,512
Cash and cash equivalents at end of period	$	10,295		$	11,061
Supplemental cash flow information:
Cash paid for taxes	$	49		$	65
Supplemental non-cash operating and financing activity:
Income tax withholdings on conversion of equity incentives	$	—		$	37
Accrued bonus paid with equity incentives	$	23		$	—

See accompanying notes.

4

AMERICAN CARESOURCE HOLDINGS, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(tables in thousands, except per share data)

1. Description of Business and Basis of Presentation

American CareSource Holdings, Inc. (“ACS,” “Company,” the “Registrant,” “we,” “us,” or “our”) is an ancillary services company that offers cost effective access to a comprehensive national network of ancillary healthcare service providers.  The Company sells its services to a number of healthcare companies including preferred provider organizations ("PPOs"), third party administrators (“TPAs”), insurance companies, large self-funded organizations, various employee groups and other middle-market organizations.  The Company offers payors this solution by:

• lowering its payors’ ancillary care costs throughout its network of high quality, cost effective providers that the Company has under contract at more favorable terms than they could generally obtain on their own;

• providing payors with a comprehensive network of ancillary healthcare service providers that is tailored to each payor’s specific needs and is available to each payor’s covered persons for covered services;

• providing payors with claims management, reporting and processing and payment services;

• performing network/needs analysis to assess the benefits to payors of adding additional/different service providers to the payor-specific provider networks; and

• credentialing network service providers for inclusion in the payor-specific provider networks.  

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), interim reporting requirements of Form 10-Q and Rule 8-03 of Regulation S-X of the rules and regulations of the Securities and Exchange Commission (“SEC”).  Consequently, financial information and disclosures normally included in financial statements prepared annually in accordance with GAAP have been condensed or omitted.  Balance sheet amounts are as of September 30, 2012 and December 31, 2011 and operating results are for the three and nine months ended September 30, 2012 and 2011, and include all normal and recurring adjustments we consider necessary for the fair, summarized presentation of our financial position and operating results.  As these are condensed financial statements, readers of this report should, therefore, refer to the consolidated financial statements and the notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, filed with the SEC on March 9, 2012.

The Company uses the “management approach” for reporting information about segments in annual and interim financial statements.  The management approach is based on the way the chief operating decision-maker organizes segments within a company for making operating decisions and assessing performance.  Reportable segments are based on products and services, geography, legal structure, management structure and any other manner in which management disaggregates a company.  Based on the “management approach” model, the Company has determined that its business is comprised of a single operating segment.

Our interim results of operations are not necessarily indicative of results of operations that will be realized for the full fiscal year.

2. Revenue Recognition

The Company recognizes revenue on the services that it provides, which includes (i) providing payor clients with a comprehensive network of ancillary healthcare providers, (ii) providing claims management, reporting, processing and payment services, (iii) providing network/need analysis to assess the benefits to payor clients of adding additional/different service providers to the client-specific provider networks and (iv) providing credentialing of network service providers for inclusion in the client payor-specific provider networks.  Revenue is recognized when services are delivered, which occurs after processed claims are billed to the client payors and collections are reasonably assured.  The Company estimates revenues and costs of revenues using average historical collection rates and average historical margins earned on claims.  Periodically, revenues are adjusted to reflect actual cash collections so that revenues recognized accurately reflect cash collected.

5

The Company determines whether it is acting as a principal or agent in the fulfillment of the services rendered.  After careful evaluation of the key gross and net revenue recognition indicators, the Company acknowledges that while the determination of gross versus net reporting is highly judgmental in nature, the Company has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting.

Following are the key indicators that support the Company’s conclusion that it acts as a principal when settling claims for service providers through its contracted service provider network:

• The Company is the primary obligor in the arrangement.  The Company has assessed its role as primary obligor as a strong indicator of gross reporting.  The Company believes that it is the primary obligor in its transactions because it is responsible for providing the services desired by its client payors.  The Company has distinct, separately negotiated contractual relationships with its client payors and with the ancillary healthcare providers in its networks.  The Company does not negotiate “on behalf of” its client payors and does not hold itself out as the agent of the client payors when negotiating the terms of the Company’s ancillary healthcare service provider agreements.  The Company’s agreements contractually prohibit client payors and service providers to enter into direct contractual relationships with one another.  The client payors have no control over the terms of the Company’s agreements with the service providers.  In executing transactions, the Company assumes key performance-related risks.  The client payors hold the Company responsible for fulfillment, as the provider, of all of the services the client payors are entitled to under their contracts; client payors do not look to the service providers for fulfillment.  In addition, the Company bears the pricing/margin risk as the principal in the transactions.  Because the contracts with the client payors and service providers are separately negotiated, the Company has complete discretion in negotiating both the prices it charges its client payors and the financial terms of its agreements with the service providers.  Since the Company’s profit is the spread between the amounts received from the client payors and the amount paid to the service providers, it bears significant pricing/margin risk.  There is no guaranteed mark-up payable to the Company on the amount the Company has contracted.  Thus, the Company bears the risk that amounts paid to the service provider will be greater than the amounts received from the client payors, resulting in a loss or negative claim.

• The Company has latitude in establishing pricing.  As stated above, the Company has complete latitude in negotiating the price to be paid to the Company by each client payor and the price to be paid to each contracted service provider.  This type of pricing latitude indicates that the Company has the risks and rewards normally attributed to a principal in the transactions.

• The Company changes the product or performs part of the services.  The Company provides the benefits associated with the relationships it builds with the client payors and the service providers.  While the parties could deal with each other directly, the client payors would not have the benefit of the Company’s experience and expertise in assembling a comprehensive network of service providers, in claims management, reporting and processing and payment services, in performing network/needs analysis to assess the benefits to client payors of adding additional/different service providers to the client payor-specific provider networks, and in credentialing network service providers.

• The Company has complete discretion in supplier selection.  One of the key factors considered by client payors who engage the Company is to have the Company undertake the responsibility for identifying, qualifying, contracting with and managing the relationships with the ancillary healthcare service providers.  As part of the contractual arrangement between the Company and its client payors, the payors identify their obligations to their respective covered persons and then work with the Company to determine the types of ancillary healthcare services required in order for the payors to meet their obligations.  The Company may select the providers and contract with them to provide services at its discretion.

• The Company is involved in the determination of product or service specifications.  The Company works with its client payors to determine the types of ancillary healthcare services required in order for the payors to meet their obligations to their respective covered persons.  In some respects, the Company is customizing the product through its efforts and ability to assemble a comprehensive network of providers for its payors that is tailored to each payor’s specific needs.  In addition, as part of its claims processing and payment services, the Company works with the client payors, on the one hand, and the providers, on the other, to set claims review, management and payment specifications.

• The supplier (and not the Company) has credit risk.  The Company believes it has some level of credit risk, but that risk is mitigated because the Company does not remit payment to providers unless and until it has received payment from the relevant client payors following the Company’s processing of a claim.

• The amount that the Company earns is not fixed.  The Company does not earn a fixed amount per transaction nor does it realize a per-person per-month charge for its services.

6

The Company has evaluated the other indicators of gross and net revenue recognition, including whether or not the Company has general inventory risk.  The Company does not have any general inventory risk, as its business is not related to the manufacture, purchase or delivery of goods and it does not purchase in advance any of the services to be provided by the ancillary healthcare service providers.  While the absence of this risk would be one indicator in support of net revenue reporting, as described in detail above, the Company has carefully evaluated all of the key gross and net revenue recognition indicators and has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting.

If the Company were to report its revenues net of provider payments rather than on a gross reporting basis, for the three and nine months ended September 30, 2012, its net revenues would have been approximately $2.1 million and $6.8 million, respectively. For the three and nine months ended September 30, 2011, its net revenues would have been approximately $2.4 million and $8.2 million, respectively.

The Company records a provision for refunds based on an estimate of historical refund amounts. Refunds are paid to payors for overpayments on claims, claims paid in error, and claims paid for non-covered services. In some instances, we will recoup payments made to the ancillary service provider if the claim has been fully resolved. The evaluation is performed periodically and is based on historical data. We present revenue net of the provision for refunds on the consolidated statement of operations.

During the three and nine months ended September 30, 2012 and 2011, two of the Company’s clients, identified in the Company's annual report on Form 10-K for the year ended December 31, 2011, comprised a significant portion of the Company’s revenues.  The following is a summary of the approximate amounts of the Company’s revenue and accounts receivable contributed by each of those clients as of the dates and for the periods presented (amounts in thousands):

				Periods ended September 30, 2012													Periods ended September 30, 2011
	As of September 30, 2012			Three months					Nine Months					As of September 30, 2011			Three months					Nine Months
	Accounts Receivable			Net Revenue			% of Total Revenue		Net Revenue			% of Total Revenue		Accounts Receivable			Net Revenue			% of Total Revenue		Net Revenue			% of Total Revenue
Material Client Relationship	$	814		$	2,508		31	%	$	8,461		33	%	$	1,627		$	3,964		34	%	$	12,142		34	%
MultiPlan, Inc. (formerly Viant Holdings, Inc.)	200			706			9		2,412			9		756			2,535			22		7,794			22
All Others	1,841			5,049			61		15,117			59		1,556			5,130			45		16,382			45
Allowance for Uncollectable Receivables/Provision for refunds	(235		)	(77		)	(1	)	(188		)	(1	)	(159		)	(133		)	(1	)	(437		)	(1	)
	$	2,620		$	8,186		100	%	$	25,802		100	%	$	3,780		$	11,496		100	%	35,881			100	%

7

3. Reverse Stock Split

On August 31, 2012 the Company filed a Certificate of Amendment to its Certificate of Incorporation, as amended (the “Amendment”) to effect a 1-for-3 reverse stock split (“reverse split”) of its common stock, par value $0.01 per share (the “Common Stock”), effective September 4, 2012 (the “Effective Day”). Because the Amendment did not result in a reduction in the number of authorized shares of Common Stock, its effect was to increase the number of shares of Common Stock available for issuance relative to the number of shares issued and outstanding. In addition, the par value per share of Common Stock remained $0.01, thus Common Stock and Additional Paid-In Capital were adjusted $114,000 to reflect the reverse split on the consolidated balance sheet.

At the Company's annual meeting of stockholders, held on June 11, 2012, the stockholders voted to amend the Company's certificate of incorporation for the purpose of effecting a reverse stock split and authorized its Board of Directors to determine, in its sole discretion, whether to effect the amendment, the timing of the amendment, and the specific ratio of the reverse stock split, provided that such ratio is 1-for-2, 1-for-2.5, 1-for-3, 1-for-3.5 or 1-for-4.

On the Effective Day, every three shares of the Company's Common Stock issued and outstanding immediately prior to the Effective Day were automatically combined into one share of Common Stock. Stockholders that were left with a fraction of a share as a result of the reverse split received cash in lieu of the fractional share in an amount based on the closing sale price of the Common Stock on the business day immediately preceding the Effective Day as reported on the The Nasdaq Capital Market. The amount paid to stockholders was less than $1,000. In addition, any options, warrants and restricted stock units outstanding as of the Effective Day were adjusted accordingly. As a result of the reverse split, the Company had 5,706,443 shares of common stock issued and outstanding as of September 30, 2012.

Shares of common stock and common stock equivalents, along with earnings per share and other per share amounts, have been retroactively restated to reflect the 1-for-3 reverse stock split that occurred on September 4, 2012 for all periods presented.

4. Earnings (Loss) Per Share

For purposes of this calculation, outstanding stock options, stock warrants, and unvested restricted stock units are considered common stock equivalents using the treasury stock method, and are the only such equivalents outstanding.  For the three and nine months ended September 30, 2012, options to purchase approximately 730,000 shares of common stock, warrants to purchase 119,445 shares of common stock and approximately 3,000 unvested restricted stock units were excluded from the calculation as their impact would be anti-dilutive.

5. Software Development Costs

The Company capitalizes costs associated with internally developed software, developed for internal use only, during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. Costs of significant upgrades and enhancements that result in additional functionality also are capitalized, whereas costs incurred for maintenance and minor upgrades and enhancements are expensed as incurred. Capitalized costs include external direct costs of materials and services utilized in developing or obtaining internal-use software and payroll and payroll-related expenses for employees who are directly associated with and devote time to the internal-use software projects. Capitalization of such costs begins when the preliminary project stage is complete and ceases no later than the point at which the project is substantially complete and ready for its intended purpose. Capitalized costs are amortized using the straight-line method over the useful life of the software, which is typically five years.

During the three and nine months ended September 30, 2012, the Company capitalized approximately $164,000 and $302,000, respectively. During the three and nine months ended September 30, 2011, the Company capitalized approximately $160,000 and $513,000, respectively.

8

6. Warrants

The Company entered into an agreement as of February 25, 2011 with an employee, whereby the Company agreed to issue warrants to purchase 83,333 shares of common stock with an exercise price of $5.01. The warrants have a term of 5 years and vest in increments over a time period of 2 years depending on the achievement of defined, agreed upon revenue targets generated by new clients. The agreement also obligates the Company to issue warrants to purchase up to an additional 166,666 shares of common stock (issued in 83,333 increments) pursuant to the achievement of additional defined agreed upon revenue targets. During the twelve months ended December 31, 2011, we did not recognize compensation costs associated with these warrants due to the low probability of vesting.

On February 1, 2012, certain terms of the agreement were modified, including the revenue targets and the total number of shares under the initial and future warrants. The warrants initially granted now cover 44,444 shares to be purchased at an exercise price of $1.50, 22,222 of which vested immediately, and the remaining 22,222 shares vesting upon the achievement of certain revenue targets. The number of shares underlying warrants to be issued under the agreement in the future was reduced to 88,889 shares (issued in 44,444 increments) based upon the achievement of additional defined agreed upon revenue targets.

During the nine months ended September 30, 2012, we recognized compensation costs of approximately $21,000 associated with the initial vesting of 22,222 shares. Additional costs associated with the warrants will be recognized based on the probability that the revenue targets will be reached. That probability will be re-evaluated and updated based on current market conditions, on a quarterly basis, and compensation costs will be adjusted accordingly.

Shares of common stock and exercise price have been restated to reflect the 1-for-3 reverse stock split that occurred on September 4, 2012.

7. Subsequent Events

We evaluate events and transactions that occur after the balance sheet date as potential subsequent events. No material event occurred subsequent to September 30, 2012.

9

FORWARD-LOOKING STATEMENTS

This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements can be identified by forward-looking words such as “may,” “will,” “expect,” “intend”, “anticipate,” “believe,” “estimate” and “continue” or similar words and discuss the Company’s plans, objectives and expectations for future operations, including its services, contain projections of the Company’s future operating results or financial condition, and discuss its expectations with respect to the growth in health care costs in the United States, the demand for ancillary benefits management services, and the Company’s competitive advantages, or contain other “forward-looking” information.

Such forward-looking statements are based on current information, assumptions and belief of management, and are not guarantees of future performance.  Substantial risks and uncertainties could cause actual results to differ materially from those indicated by such forward-looking statements, including, but not limited to, the Company’s inability to attract or maintain providers or clients or achieve its financial results, changes in national health care policy, federal or state regulation, and/or rates of reimbursement including without limitation the impact of the Patient Protection and Affordable Care Act, Health Care and Educational Affordability Reconciliation Act and medical loss ratio regulations, general economic conditions (including the economic downturns and increases in unemployment), lower than anticipated demand for ancillary services, shifts from higher margin services to services with lower profit margins, pricing, market acceptance/preference, the Company’s ability to integrate with its clients, consolidation in the industry that are impacting the Company’s key clients and the resulting transition plans, changes in the business decisions by significant clients, inability to collect on the claims billed to our clients, increased competition, implementation and performance difficulties, and other risk factors detailed from time to time in the Company’s periodic filings with the Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2011 and the quarterly reports on Form 10-Q filed for each of the subsequent quarters.

Do not place undue reliance on these forward-looking statements, which speak only as of the date this document was prepared.  All forward-looking statements included herein are expressly qualified in their entirety by the cautionary statements contained or referred to in this section.  Except to the extent required by applicable securities laws and regulations, the Company undertakes no obligation to update or revise these forward-looking statements to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events.

10

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

GENERAL

Management’s discussion and analysis provides a review of the Company’s operating results for the three and nine months ended September 30, 2012 and its financial condition at September 30, 2012.  The focus of this review is on the underlying business reasons for significant changes and trends affecting the net revenues, operating results and financial condition of the Company.  This review should be read in conjunction with the accompanying unaudited consolidated financial statements and the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2011.

OVERVIEW

American CareSource Holdings, Inc. (“ACS,” “Company,” the “Registrant,” “we,” “us,” or “our”) works to help its clients control healthcare costs by offering cost containment strategies, primarily through the utilization of a comprehensive national network of ancillary healthcare service providers.  The Company markets its services to a number of healthcare companies including third party administrators (“TPAs”), insurance companies, large self-funded organizations, various employee groups and preferred provider organizations ("PPOs").  The Company offers payors this solution by:

• lowering its payors’ ancillary care costs throughout its network of high quality, cost effective providers that the Company has under contract at more favorable terms than they could generally obtain on their own;

• providing payors with a comprehensive network of ancillary healthcare service providers that is tailored to each payor’s specific needs and is available to each payor’s members for covered services;

• providing payors with claims management, reporting and processing and payment services;

• performing network/needs analysis to assess the benefits to payors of adding additional/different service providers to the payor-specific provider networks; and

• credentialing network service providers for inclusion in the payor-specific provider networks.

The Company has assembled a network of ancillary healthcare service providers that supplement or support the care provided by hospitals and physicians and includes 30 service categories. We have a dedicated provider development function comprised of eight full-time employees, whose primary responsibility is to contract with providers and strategically grow our network of ancillary service providers.

We secure contracts with ancillary service providers by offering them the following:

• inclusion in a nationwide network that provides exposure to our client payors and their aggregate member lives;

• an array of administrative and back-office services, such as collections and appeals;

• increased claims volume through various "soft steerage" mechanisms; and    

• advocacy in the claims appeals process.

11

The Company’s business model, illustrating the relationships among the persons involved, directly or indirectly, in the Company’s business and its generation of revenue and expenses, is depicted below:

Payors route healthcare claims to us after service has been performed by participant providers in our network.  We process those claims and charge the payor according to its contractual rate for the services according to our contract with the payor.  In processing the claim, we are paid directly by the payor or the insurer for the service.  We then pay the provider of service according to its independently-negotiated contractual rate.  We assume the risk of generating positive margin, the difference between the payment we receive for the service and the amount we are obligated to pay the provider of service.

The Company recognizes revenues for ancillary healthcare services when services by providers have been authorized and performed, the claim has been billed to the payor and collections from payors are reasonably assured.  Cost of revenues for ancillary healthcare services consist of amounts due to providers for providing ancillary healthcare services, client administration fees paid to our client payors to reimburse them for routing the claims to us for processing, and the Company’s related direct labor and overhead of processing billings, collections and payments. The Company is not liable for costs incurred by independent contract service providers until payment is received by it from the payors. The Company recognizes actual or estimated liabilities to independent contract service providers as the related revenues are recognized.

The Company is seeking growth in the number of client payors and service provider relationships it secures by focusing on providing in-network services for its payors and aggressively pursuing additional TPAs, self-insured employers and other direct payors as its primary sales targets. The Company believes this strategy should increase the volume of claims the Company can process in addition to the expansion in the number of lives that are eligible to receive ancillary healthcare benefits.  No assurances can be given that the Company can expand its service provider or payor relationships, nor that any such expansion will result in an improvement in the results of operations of the Company.

In addition, under the Minimum Loss Ratio ("MLR") regulations included in the Affordable Care Act, it is possible that a portion of the fees our existing and prospective payors are contractually required to pay us and that do not qualify as 'incurred claims' may not be included as expenditures for activities that improve healthcare quality. Such a determination may make it more difficult for us to retain existing clients and/or add new clients,because our clients' or prospective clients' MLR may otherwise not meet the specified targets. This may reduce our net revenues and profit margins. See "Recent and pending healthcare reforms could materially adversely affect our revenues, financial position and our results of operations" under "Item 1.A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2011.

12

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Management’s discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements.  These condensed consolidated financial statements have been prepared following the requirements of accounting principles generally accepted in the United States (“GAAP”) for interim periods and require us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.  On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, provider cost recognition, the resulting contribution margins, potential impairment of intangible assets and stock-based compensation expense.  As these are condensed consolidated financial statements, you should also read expanded information about our critical accounting policies and estimates provided in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” under the heading “Critical Accounting Policies,” included in our Annual Report on Form 10-K for the year ended December 31, 2011.  There have been no material changes to our critical accounting policies and estimates from the information provided in our Form 10-K for the year ended December 31, 2011.

OVERVIEW

We have experienced revenue declines over the past three years (including 2012), primarily related to the declines in the business of our two largest clients, both of which are preferred provider organizations ("PPOs"). Due to a variety of factors affecting the healthcare industry generally, the economy and for other reasons, revenue from each of our two largest clients continued to decline (with downturns in their own businesses) resulting in year-over-year quarterly declines in our revenue from those accounts that ranged between 15% and 57% during the periods between 2010 and the current quarter. Because of the significance of the revenue concentration from these two clients (approximately 98% in 2008), the declines of the business of these clients has had a significant negative impact on our operating results and cash position over the past three years (including 2012 to date), despite our new business development efforts.

In 2010, we began focusing our sales efforts on third-party administrators ("TPAs"), insurance companies, self-funded organizations, employer groups and direct payors, as we believe we can more competitively impact those relationships. TPAs, in their fiduciary capacity, assist their clients (primarily employer groups) with cost containment; the ancillary network solution we provide is a valuable component to add to a TPA's portfolio. There are approximately 500 TPAs nationwide, with approximately 20% of those being our target market. According to research reported by the Employee Benefit Research Institute, as recently as 2008, approximately 55% of employees with health insurance were covered by a self-insured plan. In light of changes in healthcare legislation and the size of the self-insured market, we believe that TPAs are an important element of that market, with needs that we can address, primarily from a cost containment standpoint.

We added 13 new clients in 2010, which generated approximately $5.9, $11.9, and $8.9 million of revenue in 2010 through 2012, respectively. While those accounts contribute an estimated $11-13 million of revenue annually, they have only partially offset the revenue declines from our significant legacy clients. During 2011, we signed only four new accounts. During the nine months ended September 30, 2012, we have signed four new accounts, of which, three are TPAs. None of the four accounts have made significant revenue contributions or have had a material impact on our consolidated results of operations during 2012.

Early in 2012, we made investments in our sales function in an effort to expand sales distribution channels, improve sales processes, evaluate marketing opportunities and most importantly, increase our number of sales personnel, which was four at September 30, 2012, compared to 2.5 full-time employees during most of 2011. Additionally, we have engaged two sales consultants, each of whom has an extensive background in the healthcare industry. In connection with our efforts to diversify revenue and identify expanded business opportunities, during the three months ended September 30, 2012, we invested $107,000 in a software solution intended to enhance delivery of the Company's network of ancillary service providers as part of a cost containment solution. The Company will make additional payments totaling approximately $198,000 over the next five months relating to such efforts. The Company believes that it has a unique business model and offers a solid value proposition to our clients, as well as our providers, by delivering superior discounts through our network of contracted ancillary healthcare service providers. In 2012, the Company's objectives continue to be to (1) add new significant client contracts, (2) control our cost structure to limit operating losses, (3) preserve our existing cash balances for investments in the business model and/or other strategic initiatives, and (4) investigate and identify strategic initiatives that the Company can execute in the short and long-term that will bring value to our stockholders. Nevertheless, until we can replace a greater amount of the revenue than we have lost from our two largest clients, we will continue to experience operating losses and use our existing cash reserves for operating and investing activities.

13

ANALYSIS OF RESULTS OF OPERATIONS

The following table sets forth a comparison of our results of operations for the following periods presented:

	Third Quarter											Nine Months
							Change											Change
	2012			2011			$			%		2012			2011			$			%
Net revenue	$	8,186		$	11,496		$	(3,310	)	(28.8	)%	$	25,802		$	35,881		$	(10,079	)	(28.1	)%
Variable costs:
Provider payments	6,119			9,091			2,972			32.7		18,992			27,715			8,723			31.5
Administrative fees	340			616			276			44.8		1,168			1,791			623			34.8
Total variable costs	6,459			9,707			3,248			33.5		20,160			29,506			9,346			31.7
Percent of net revenue	78.9		%	84.4		%						78.1		%	82.2		%
Variable flowthrough	1,727			1,789			(62		)	(3.5	)	5,642			6,375			(733		)	(11.5	)
Variable margin	21.1		%	15.6		%						21.9		%	17.8		%
Non-variable costs:
Claims administration	624			740			116			15.7		1,983			2,392			409			17.1
Provider development	298			327			29			8.9		882			1,054			172			16.3
Sales & marketing	498			321			(177		)	(55.1	)	1,564			999			(565		)	(56.6	)
Finance & administration	1,156			1,390			234			16.8		2,985			3,727			742			19.9
Total non-variable costs	2,576			2,778			202			7.3		7,414			8,172			758			9.3
Percent of net revenue	31.5		%	24.2		%						28.7		%	22.8		%
Loss before depreciation, amortization, and income taxes	(849		)	(989		)	140			14.2		(1,772		)	(1,797		)	25			1.4
Percent of net revenue	(10.4		)%	(8.6		)%						(6.9		)%	(5.0		)%
Goodwill impairment charge	—			4,361			4,361			100.0		—			4,361			4,361			100.0
Depreciation and amortization	222			204			(18		)	(8.8	)	662			585			(77		)	(13.2	)
Income tax provision (benefit)	4			969			965			(99.6	)	28			647			619			(95.7	)
Net loss	$	(1,075	)	$	(6,523	)	$	5,448		83.5	%	$	(2,462	)	$	(7,390	)	$	4,928		66.7	%

The following discussion compares the historical results of operations on a basis consistent with GAAP for the three and nine months ended September 30, 2012 and 2011.

Net Revenues

The Company’s net revenues are generated from ancillary healthcare service claims.  Revenue is recognized when we bill our client payors for services performed and collection is reasonably assured. The Company estimates revenues using average historical collection rates.  When estimating collectibility, we assess the impact of items such as non-covered benefits, denied claims, deductibles and co-payments. Periodically, revenues and related estimates are adjusted to reflect actual cash collections so that revenues recognized accurately reflect cash collected. There are no assurances that actual cash collections will meet or exceed estimated cash collections.

14

The following tables set forth a comparison of our net revenues and billed claims for the following periods presented ended September 30 (in thousands):

	Net Revenue											Billed Claims Volume
	Third Quarter						Change					Third Quarter		Change
(in thousands)	2012			2011			$			%		2012	2011	Claims		%
Legacy clients:
Material Client Relationship	$	2,508		$	3,964		$	(1,456	)	(37	)%	8	18	(10	)	(56	)%
MultiPlan, Inc. (formerly Viant, Inc.)	706			2,535			(1,829		)	(72	)	3	10	(7	)	(70	)
Principal Life Insurance Company	4			544			(540		)	(99	)	—	2	(2	)	(100	)
Other legacy clients	1,713			1,428			285			20		11	13	(2	)	(15	)
Sub-total	4,931			8,471			(3,540		)	(42	)	22	43	(21	)	(49	)
Clients implemented in 2010 - 2012	3,332			3,158			174			6		15	18	(3	)	(17	)
Total gross revenue	$	8,263		$	11,629		$	(3,366	)	(29	)%	37	61	(24	)	(39	)%
Provision for refunds	(77		)	(133		)	56			(42	)	—	—	—		nm
Net Revenue	$	8,186		$	11,496		$	(3,310	)	(29	)%	37	61	(24	)	(39	)%

	Net Revenue											Billed Claims Volume
	Nine Months						Change					Nine Months		Change
(in thousands)	2012			2011			$			%		2012	2011	Claims		%
Legacy clients:
Material Client Relationship	$	8,461		$	12,142		$	(3,681	)	(30	)%	28	58	(30	)	(52	)%
MultiPlan, Inc. (formerly Viant, Inc.)	2,412			7,794			(5,382		)	(69	)	12	34	(22	)	(65	)
Principal Life Insurance Company	47			2,067			(2,020		)	(98	)	—	9	(9	)	(100	)
Other legacy clients	5,191			5,272			(81		)	(2	)	38	44	(6	)	(14	)
Sub-total	16,111			27,275			(11,164		)	(41	)	78	145	(67	)	(46	)
Clients implemented in 2010 - 2012	9,879			9,043			836			9		45	51	(6	)	(12	)
Total gross revenue	$	25,990		$	36,318		$	(10,328	)	(28	)%	123	196	(73	)	(37	)%
Provision for refunds	(188		)	(437		)	249			(57	)	—	—	—		nm
Net Revenue	$	25,802		$	35,881		$	(10,079	)	(28	)%	123	196	(73	)	(37	)%

In addition, the following table sets forth a comparison of processed and billed claims for the following periods presented ended September 30 (in thousands):

	Third Quarter						Nine Months
			Change						Change
(in thousands)	2012	2011	Claims		%		2012	2011	Claims		%
Processed	46	73	(27	)	(37	)%	154	240	(86	)	(36	)%
Billed	37	61	(24	)	(39	)	123	196	(73	)	(37	)

15

Following is a discussion of the changes in net revenue generated by significant client/client groupings for the three and nine months ended September 30, 2012 as compared to the same period in 2011:

Material Client Relationship

The decline in billed claims volume from our relationship with one of our material clients for the three and nine months ended September 30, 2012 is due to the following factors:

• The client continues to suffer attrition in its client base, resulting in declines in claims volume.

• Early in 2012, we were informed by our client that it commenced a technology platform conversion, which disrupted the claims flow. That disruption negatively impacted our revenue, as we did not receive all claims related to specialty services provided, and the disruption caused claims data to be omitted which inhibited collectibility. Our revenue/collection estimates are lower for the three and nine months ended September 30, 2012, compared to the prior year periods.

• Laboratory service claims from the client declined 78% and 62% for the three and nine months ended September 30, 2012, respectively. The declines in claim count resulted in estimated declines in revenue of approximately $270,000 and $720,000 for the three and nine months, respectively.

• The client lost a significant employer group which accounted for approximately $535,000 of revenue to us during the nine months ended September 30, 2011. No revenue from the client was generated during the three and nine months ended September 30, 2012.

The performance of the client account during the remainder of 2012 will be affected by attrition in its own client base, its internal strategic initiatives and further technology infrastructure changes. We do not expect that we will maintain a level of revenue consistent with the first nine months of 2012 or the prior year. In addition, the term of the current contract amendment expires on December 31, 2012. While we are engaged in discussions relating to a renewal of the agreement, there can be no assurances that we will reach an agreement or that the relationship will continue subsequent to December 31, 2012. In any event, we expect that even if a new agreement is reached, revenue from this client will likely continue to decline.

MultiPlan, Inc. (formerly Viant Holdings, Inc.)

The decline in net revenue and billed claims volume from our relationship with MultiPlan, Inc. ("MultiPlan") is due to the acquisition by MultiPlan of Viant Holdings, Inc. As part of that transition, MultiPlan is methodically moving its payors and employers groups to its existing networks. The transition commenced in mid-2010 and is estimated to be complete at the end of 2012 at which time we do not expect any significant revenue contributions from the account.

Principal Life Insurance Company

As was announced publicly in late-2010, Principal Life Insurance Company ("Principal") exited the health insurance business. During the course of 2011, Principal transitioned its existing members and groups, which resulted in revenue of $544,000 and $2.1 million to us in the three and nine months ended September 30, 2011, respectively. We do not expect to generate meaningful revenue or claims volume from the account in the remaining part of 2012.

Other Legacy Clients

Our other legacy clients consist of 11 various relationships with PPOs, insurance companies and direct payors that were contracted between 2005 and 2009. Most of the accounts have matured and there are only limited opportunities for growth. Through our account management group, we maintain contact with these clients to determine if opportunities exist to serve the accounts and generate incremental revenue.

For the three months ended September 30, 2012, revenue for this client group increased 20%, or $285,000, as a result of a shift in specialty billed mix, which impacted three of our clients within this group. These clients experienced substantial increases in billings for specialty services, which historically carry higher collection rates. A change in patient and specialty mix, as well as benefit plan design changes, is not a factor controlled by us. This increase was partially offset by a client account, which continues to experience attrition within its own client base.

16

For the nine months ended September 30, 2012, revenue from this client group was flat (declined $81,000 or 2%) compared to the same period in 2011. While there are limited opportunities for growth in these accounts, revenue is impacted most significantly by the mix of specialties utilized and those specialties' associated collection rates, and the clients' ability to maintain its own book of business.

The 15% and 14% decline in billed claims volume for this client group for the three and nine months ended September 30, 2012, respectively, is primarily attributable to a client, which has experienced attrition in its own client base during the third quarter and technology issues early in 2012.

Clients implemented in 2010 - 2012

The 13 clients implemented in 2010 consist of 12 TPAs and one PPO, and are the results of the initial stages of our focus on TPAs and direct payors. The accounts generated revenue of approximately $11.9 million during 2011. Through our account management group, we work with these clients to determine ways in which we can bring value to the relationships and to add our network to incremental employer groups in order to maximize our revenue opportunity.

The 17% and 12% decline in billed claims volume for this client group for the three and nine months ended September 30, 2012, respectively, is primarily attributable to issues experienced by our only PPO client within this group. Our account management group is working closely with the client to ensure they are receiving the maximum benefit from our network of ancillary healthcare service providers.

During the three and nine months ended September 30, 2012, revenue for this client group, as a whole, increased 6% and 9%, respectively, as compared to the same prior year periods. The increase in revenue for this client group during the three and nine months ended September 30, 2012 is due to the following factors:

• During the nine months ended September 30, 2012, continuing our strategy to pursue TPAs and direct payors, we implemented four new clients. These new clients contributed incremental revenue of approximately $133,000 and $163,000 for the three and nine months ended September 30, 2012, respectively.

• We implemented four new clients over the course of 2011. For the nine months ended September 30, 2012, those four accounts contributed incremental revenue of $214,000 compared to the same period in the prior year; and

• Several of our clients added employer groups that previously were not utilizing our network of ancillary providers. Those groups generated incremental revenue during the third quarter and first nine months of 2012;

The growth was generated primarily from the accounts implemented in 2010, most of which are TPAs and direct payors. For the nine months ended September 30, 2012 and 2011, the accounts implemented in 2010 have generated revenue of approximately $8.9 million and $8.4 million, respectively.

The following tables detail the change in revenue generated from different client types (includes all Company clients) for the periods ended September 30:

	Third Quarter
	2012					2011					Change
($ in thousands)	Count	Revenue		% of revenue		Count	Revenue		% of revenue		$			%
TPAs	27	$	3,940	47.7	%	23	$	3,505	30.1	%	$	435		12	%
PPOs	11	3,635		44.0		11	6,782		58.4		(3,147		)	(46	)
Direct/Insurance Companies	3	647		7.8		3	1,342		11.5		(695		)	(52	)
Other	1	41		0.5		—	—		—		41			nm
Gross revenue, before provision for refunds		$	8,263	100.0	%		$	11,629	100.0	%	$	(3,366	)	(29	)%

17

	Nine Months
	2012					2011					Change
($ in thousands)	Count	Revenue		% of revenue		Count	Revenue		% of revenue		$			%
TPAs	27	$	12,367	47.6	%	23	$	11,476	31.6	%	$	891		8	%
PPOs	11	11,624		44.7		11	20,243		55.7		(8,619		)	(43	)
Direct/Insurance Companies	3	1,945		7.5		3	4,599		12.7		(2,654		)	(58	)
Other	1	54		0.2		—	—		—		54			nm
Gross revenue, before provision for refunds		$	25,990	100.0	%		$	36,318	100.0	%	$	(10,328	)	(28	)%

Variable Costs

Variable costs are comprised of payments to our providers and administrative fees paid to our clients for converting claims to electronic data interchange and routing them to both the Company for processing and to their payors for payment.  Payments to providers are the most significant variable cost and it consists of our payments for ancillary care services in accordance with contracts negotiated separately with providers for specific ancillary services.

The following tables set forth a comparison of the variable cost components of our cost of revenues, for the periods presented ended September 30:

	Third Quarter
									Change
($ in thousands)	2012		% of net revenue		2011		% of net revenue		$			%
Provider payments	$	6,119	74.7	%	$	9,091	79.1	%	$	(2,972	)	(33	)%
Administrative fees	340		4.2		616		5.4		(276		)	(45	)
Total variable costs	$	6,459	78.9	%	$	9,707	84.5	%	$	(3,248	)	(33	)%

	Nine Months
									Change
($ in thousands)	2012		% of net revenue		2011		% of net revenue		$			%
Provider payments	$	18,992	73.6	%	$	27,715	77.2	%	$	(8,723	)	(31	)%
Administrative fees	1,168		4.5		1,791		5.0		(623		)	(35	)
Total variable costs	$	20,160	78.1	%	$	29,506	82.2	%	$	(9,346	)	(32	)%

Provider payments

The 33% and 31% decrease in provider payments for the third quarter and first nine months of 2012 is consistent with the decline in revenue as discussed above. The decrease in provider payments as a percentage of net revenues compared to the same prior year periods is primarily due to the following:

• A shift in mix from clients that generate lower margins, relative to other clients, primarily MultiPlan. MultiPlan generated approximately 9% of our net revenue in the third quarter and first nine months of 2012, as compared to approximately 22% in each of the same periods in 2011; and

• A shift in mix towards higher margin categories, such as laboratory services, durable medical equipment, infusion services and surgery centers, away from lower margin categories, such as dialysis services.

Administrative fees

Administrative fees paid to clients as a percent of net revenues were 4.2% and 5.4% for the three months ended September 30, 2012 and 2011. Additionally, administrative fees paid to clients during the nine months ended September 30, 2012 decreased to 4.5% compared to 5.0% in the same prior year period. The decrease is due to a change in mix from clients with higher administrative fees to clients with lower administrative fees.

18

Non-variable Costs

Non-variable costs are those that are not contingent on claims activity and are fixed in nature, but can be adjusted. They are comprised of such expenses as salaries and benefits, professional fees, consulting costs, non-cash equity compensation costs and travel and entertainment expenses. A significant driver of these costs are headcount, as payroll, commissions and related benefits (including non-cash equity compensation) accounted for approximately 60% of our non-variable cost structure during the nine months ended September 30, 2012. Our headcount of full-time employees ("FTE's") was 55 and 61 at September 30, 2012 and 2011, respectively.

Following is a discussion of the changes in non-variable costs and related drivers:

Claims administration

Our claims administration function consists of our operations and information technology groups.  Our operations group is responsible for all aspects of claims management and processing, including billing, quality assurance and collection efforts. In addition, our operations group is responsible for credentialing contracted ancillary service providers.  Our information technology group is responsible for maintaining and enhancing the technological capabilities and applications of the claims management process.  

We adjust the headcount of our operations group consistent with the level of claims we process and bill. The following table sets forth a comparison of processed and billed claims for the following periods presented ended September 30 (in thousands):

	Third Quarter						Nine Months
			Change						Change
(in thousands)	2012	2011	Claims		%		2012	2011	Claims		%
Processed	46	73	(27	)	(37	)%	154	240	(86	)	(36	)%
Billed	37	61	(24	)	(39	)	123	196	(73	)	(37	)

Accordingly, we had 19 FTE's in our operations group at September 30, 2012 compared to 21 FTE's as of September 30, 2011. Currently, we process approximately 90% of our claims electronically, making our processes scalable. In the event that we add a significant number of new clients, we don't anticipate the need to make significant investments in our operations group.

Since September 30, 2011, we eliminated two positions in our information technology group as a result of natural attrition, consistent with our focus on controlling costs. In the event of significant strategic information technology initiatives, we may increase our headcount in the future.

Provider Development

Our provider development function is responsible for developing our network of ancillary healthcare service providers, which includes contracting with providers to be included in the network and maintaining a relationship with existing providers, all for the purpose of enhancing our ancillary service provider network for our client payors. We customize networks for our clients, thus as new client contracts are secured, our recruiting activities will increase. While we anticipate having the capacity to increase our activities with our existing headcount, it is possible that if a significant number of clients are added, we will increase headcount in our provider development function.

We had eight FTE's in our provider development group at September 30, 2012 compared to nine FTE's as of September 30, 2011. The 9% decrease in costs related to the provider development function during the three months ended September 30, 2012 as compared to the same prior year period is a result of the headcount reduction and lower overall benefit costs.

Sales and Marketing

Our sales and marketing function consists of our sales and account management groups. Our sales group is primarily responsible for securing new client contracts, while our account management group maintains our existing client relationships, as well as attempts to generate incremental growth from those relationships. The 55% and 57% increase in sales and marketing costs during the three and nine months ended September 30, 2012 as compared to the same prior year periods is a result of the following:

19

• Increases of approximately $115,000 and $346,000, for the respective periods noted above, are for consulting costs related to (1) the engagement of a consulting firm to lead a major initiative to invest in and improve our sales and marketing function; and (2) engagement of strategic consultants to investigate other sales opportunities outside of the traditional group health market.

• The addition of two sales resources to complement our external sales efforts as well as the addition of one account manager. As of September 30, 2012, we had four FTE's in our external sales force and three FTE's in the account management group.

Finance and Administration

Our finance and administration function consists primarily of human resources, finance and accounting as well as our Chief Executive Officer, President and Chief Operating Officer and Chief Financial Officer.

For the three months ended September 30, 2012, expenses decreased 17% due to a restructuring charge of $263,000 recorded in the third quarter of 2011. Excluding this charge, finance and administration expenses for the three months ended September 30, 2012 increased 3% compared to the same prior year period.

The 20% decrease in the finance and administration function for the nine months ended September 30, 2012 is primarily due to the restructuring charge in 2011 discussed above and the reduction in headcount. As of September 30, 2012, we had ten FTE's in the function, as compared to 13 FTE's at September 30, 2011. The three additional positions in 2011 were held by higher-salaried employees relative to other salaried employees in the function; therefore, the reduction in headcount significantly impacted the overall expenses for the nine months ended September 30, 2012. The decline in headcount is due to natural attrition, which is gradual reduction in the number of employees by natural or voluntary means. In addition, investor relations expense, bank service fees and recruiting costs decreased $189,000 as a result of utilizing lower cost consultants and vendors. However, the decreases discussed above were partially offset by $326,000 in professional fees incurred during the second and third quarters of 2012 related to various strategic initiatives and the review of the organization's structure and alignment.

Selling, General and Administrative Expenses

Following is a table showing the components of selling, general and administrative (“SG&A”) expenses as presented per the Statement of Operations for the periods presented ending September 30:

	Third Quarter											Nine Months
							Change											Change
($ in thousands)	2012			2011			$			%		2012			2011			$			%
Sales and marketing	$	498		$	321		$	(177	)	(55	)%	$	1,564		$	999		$	(565	)	(57	)%
Finance and administration	1,156			1,390			234			17		2,985			3,727			742			20
Selling, general and administrative expenses	$	1,654		$	1,711		$	57		3	%	$	4,549		$	4,726		$	177		4	%
Percentage of total net revenues	20.2		%	14.9		%						17.6		%	13.2		%

SG&A expenses as a percentage of total net revenues increased during the three and nine months ended September 30, 2012 compared to the same prior year periods, due primarily to the decline in net revenues compared to the same prior year periods.

Goodwill Impairment Charge

During the three months ended September 30, 2011 results of operations were impacted by a non-cash goodwill impairment charge of $4.4 million, which represented the entire balance of goodwill. A deferred tax benefit of $1.5 million was recognized as of September 30, 2011 as a result of the total amount of estimated impairment charge, but a valuation allowance was immediately provided.

The impairment was indicated as a result of the decline in the Company's stock price which the Company believes was caused by the continued declines in revenue and claims volume from the Company's two most significant clients and the expectation of significantly diminishing revenue from at least one of these clients. The impairment did not impact cash flows.

20

FINANCIAL CONDITION AND LIQUIDITY

As of September 30, 2012 the Company had working capital of $9.4 million compared to $11.3 million at December 31, 2011.  Our cash and cash equivalents balance decreased to $10.3 million as of September 30, 2012 compared to $11.3 million at December 31, 2011. We continued to experience a decline in claims volume and resulting revenue, resulting in a net loss during the nine months ended September 30, 2012 which expended cash despite our cost containment measures. The table below reconciles the loss before income taxes to the net decrease in cash for the nine months ended September 30, 2012.

	Nine months ended September 30, 2012
Loss before income taxes	$	(2,434	)
Depreciation and amortization	662
Non-cash stock-based compensation expense	333
Amortization of long-term client agreement	187
Payment of annual premiums for property and casualty insurance, net of amounts amortized	(92		)
Capital expenditures (primarily software development costs)	(402		)
Other working capital changes	726
Decrease in cash for the nine months ended September 30, 2012	$	(1,020	)

We believe our current cash balance of $10.3 million as of September 30, 2012 and expected future cash flows from operations will be sufficient to meet our anticipated cash needs for working capital, capital expenditures and other activities through the foreseeable future.  However, our continuing losses will continue to reduce our available cash. We have reduced our non-variable cost structure to preserve our existing cash balances for investments in the business model and/or other strategic initiatives. If operating cash flows are not sufficient to meet our needs, we believe that credit or access to capital through issuance of equity would be available to us. However, as a result of the tightening in the credit markets, low level of liquidity in many financial markets and extreme volatility in fixed income, credit, currency and equity markets, there cannot be assurances that, if necessary, we would be successful in obtaining sufficient capital financing on commercially reasonable terms or at all.  We do not have any lines of credit, credit facilities or outstanding bank indebtedness as of September 30, 2012.

INFLATION

Inflation did not have a significant impact on the Company’s costs during the quarters ended September 30, 2012 and September 30, 2011, respectively.  The Company continues to monitor the impact of inflation in order to minimize its effects through pricing strategies, productivity improvements and cost reductions.

OFF-BALANCE SHEET ARRANGEMENTS

The Company does not have any off-balance sheet arrangements as of September 30, 2012 or 2011 or for the periods then ended.

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

21

ITEM 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures.  Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2012.  Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are effective to ensure that information required to the disclosed by us  in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

Changes in Internal Controls Over Financial Reporting.  Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has concluded that there were no changes in the Company’s internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) since the last fiscal quarter that have materially affected the Company’s internal controls over financial reporting or are reasonably likely to materially affect internal controls over financial reporting. 

22

PART II. OTHER INFORMATION

ITEM 1A. Risk Factors

The Company has experienced declining revenue over the last two years primarily as a result of the decline in business from its two largest clients. During the first nine months of 2012, our largest client commenced a technology platform conversion, which disrupted claims flow and continued to suffer attrition in its client base. Our second largest client continues to transition following a business combination. This client continues to migrate its payors and employee groups to network alternatives, negatively impacting the claims volume from this client. We anticipate the transition to continue through 2012 and be complete by December 31, 2012. Although we continue to seek new clients and to expand our product offerings, we expect that our revenues will continue to decline over the next several quarters while we explore various options to offset revenue declines and return to profitability. In addition, the current amendment to the contract with our largest client expires on December 31, 2012. While we are engaged in discussions relating to a renewal of the agreement, there can be no assurances that we will reach an agreement or that the relationship will continue subsequent to December 31, 2012. In any event, we expect that even if a new agreement is reached, revenue from this client will likely continue to decline. As losses continue, our available cash will continue to decline.

In addition to the other information set forth in this report, one should carefully consider the discussion of various risks and uncertainties contained in Part I, “Item 1A.  Risk Factors” in our 2011 Annual Report on Form 10-K.  We believe those risk factors are the most relevant to our business and could cause our results to differ materially from the forward-looking statements made by us.  

ITEM 5. Other Information

On September 21, 2011, the Company received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) stating that for 30 consecutive business days immediately preceding the date of the letter the Company's common stock did not maintain a minimum closing bid price of $1.00 per share (“Minimum Bid Price Requirement”) as required by NASDAQ Listing Rule 5550(a)(2). The Company was provided 180 calendar days, or until March 19, 2012, to regain compliance.

In a letter dated March 20, 2012, NASDAQ stated that although the Company had not regained compliance with the Minimum Bid Price Requirement by March 19, 2012, it is eligible for an additional 180-day compliance period, or until September 17, 2012, based on the Company meeting the continued listing requirements for market value of publicly held shares and all other applicable standards for initial listing on the NASDAQ Capital Market (except for the Minimum Bid Price Requirement) and having notified NASDAQ of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

At the Company's annual meeting of stockholders, held on June 11, 2012, the stockholders voted to amend the Company's certificate of incorporation for the purposes of effecting a reverse stock split and authorized its Board of Directors to determine, in its sole discretion, whether to effect the amendment, the timing of the amendment, and the specific ratio of the reverse stock split, provided that such ratio is 1-for-2, 1-for-2.5, 1-for-3, 1-for-3.5 or 1-for-4.  

On August 31, 2012 the Company filed a Certificate of Amendment to its Certificate of Incorporation, as amended (the “Amendment”) to effect a 1-for-3 reverse stock split (“reverse split”) of its common stock, par value $0.01 per share (the “Common Stock”), effective September 4, 2012 (the “Effective Day”). Because the Amendment did not result in a reduction in the number of authorized shares of Common Stock, its effect was to increase the number of shares of Common Stock available for issuance relative to the number of shares issued and outstanding.

On the Effective Day, every three shares of the Company's Common Stock issued and outstanding immediately prior to the Effective Day were automatically combined into one share of Common Stock. Stockholders that were left with a fraction of a share as a result of the reverse split received cash in lieu of the fractional share in an amount based on the closing sale price of the Common Stock on the business day immediately preceding the Effective Day as reported on the The Nasdaq Capital Market. In addition, any options, warrants and restricted stock units outstanding as of the Effective Day were adjusted accordingly. As a result of the reverse split, the Company had 5,706,443 shares of common stock issued and outstanding as of September 30, 2012.

On September 18, 2012, the Company received notification from NASDAQ that the Company was in compliance with the Minimum Bid Price Requirement.

23

ITEM 6. Exhibits

Exhibit 3.1	Certificate of Incorporation, as amended
Exhibit 31.1	Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 31.2	Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 32.1	Certifications Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 101	The following financial statements and footnotes from the American CareSource Holdings, Inc. Quarterly Report on Form 10-Q for the quarter ended September 30, 2012 formatted in Extensible Business Reporting Language (XBRL): (i) Consolidated Statements of Operations; (ii) Consolidated Balance Sheets; (iii) Consolidated Statement of Stockholders' Equity; (iv) Consolidated Statements of Cash Flows; and (v) the Notes to Unaudited Consolidated Financial Statements.*

*Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections

24

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		AMERICAN CARESOURCE HOLDINGS, INC.
Date:	November 9, 2012	By:	/s/ Kenneth S. George
			Kenneth S. George
			Chairman of the Board of Directors and Chief Executive Officer (Principal Executive Officer)

Date:	November 9, 2012	By:	/s/ Matthew D. Thompson
			Matthew D. Thompson
			Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

25

EX-3.1

Exhibit 3.1

CERTIFICATE OF INCORPORATION

OF

AMERICAN CARESOURCE HOLDINGS, INC.

THE UNDERSIGNED, for the purpose of forming a corporation pursuant to the provisions of the General Corporation Law of the State of Delaware, does hereby certify as follows:

FIRST:    The name of the corporation is AMERICAN CARESOURCE HOLDINGS, INC. (the “Corporation”).

SECOND:     The address of the Corporation's registered office in the State of Delaware is c/o National Registered Agents, Inc., 9 East Loockerman Street, Suite 1B, Dover, Delaware 19901, Kent County. The name of its registered agent at such address is National Registered Agents, Inc.

THIRD:    The purpose for which the Corporation is organized is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware.

FOURTH:    The total number of shares of capital stock which the Corporation shall have authority to issue is 3,000 shares of common stock, $.01 par value per share.

FIFTH:    Subject to the provisions of the General Corporation Law of the State of Delaware, the number of Directors of the Corporation shall be determined as provided by the By-Laws.

SIXTH:    The Corporation shall indemnify and hold harmless any director, officer, employee or agent of the Corporation from and against any and all expenses and liabilities that may be imposed upon or incurred by him in connection with, or as a result of, any proceeding in which he may become involved, as a party or otherwise, by reason of the fact that he is or was such a director, officer, employee or agent of the Corporation, whether or not he continues to be such at the time such expenses and liabilities shall have been imposed or incurred, to the extent permitted by the laws of the State of Delaware, as they may be amended from time to time.

- 1 -

SEVENTH:    No person who is or was at any time a director of the Corporation shall be personally liable to the Corporation or its stockholders for monetary damages for any breach of fiduciary duty by such person as a director; provided, however, that, unless and except to the extent otherwise permitted from time to time by applicable law, the provisions of this Article SEVENTH shall not eliminate or limit the liability of a director (i) for breach of the director's duty of loyalty to the Corporation or its stockholders, (ii) for any act or omission by the director which is not in good faith or which involves intentional misconduct or a knowing violation of law, (iii) under Section 174 of the General Corporation Law of the State of Delaware, or (iv) for any transaction from which the director derived an improper personal benefit. No amendment to or repeal of this Article SEVENTH shall apply to or have any effect on the liability or alleged liability of any director of the Corporation for or with respect to any act or omission of such director occurring prior to such amendment or repeal.

EIGHTH:    In furtherance and not in limitation of the general powers conferred by the laws of the State of Delaware, the Board of Directors is expressly authorized to make, alter or repeal the By-Laws of the Corporation, except as specifically stated therein.

NINTH:    Whenever a compromise or arrangement is proposed between this Corporation and its creditors or any class of them and/or between this Corporation and its stockholders or any class of them, any court of equitable jurisdiction within the State of Delaware may, on the application in a summary way of this Corporation or of any creditor or stockholder thereof or on the application of any receiver or receivers appointed for this Corporation under the provisions of Section 291 of Title 8 of the Delaware Code or on the application of trustees in dissolution or of any receiver or receivers appointed for this Corporation under the provisions of Section 279 of Title 8 of the Delaware Code, order a meeting of the creditors or class of creditors, and/or of the stockholders or class of stockholders of this Corporation, as the case may be, to be summoned in such manner as the said Court directs. If a majority in number representing three-fourths in value of the creditors or class of creditors, and/or of the stockholders or class of stockholders of this Corporation, as the case may be, agree to any compromise or arrangement and to any reorganization of this Corporation as a consequence of such compromise or arrangement, the said compromise or arrangement and the said reorganization shall, if sanctioned by the Court to which the said application has been made, be binding on all the creditors or class of creditors, and/or on all the stockholders or class of stockholders of this Corporation, as the case may be, and also on this Corporation.

- 2 -

TENTH:    Except as otherwise required by the laws of the State of Delaware, the stockholders and Directors shall have the power to hold their meetings and to keep the books, documents and papers of the Corporation outside of the State of Delaware, and the Corporation shall have the power to have one or more offices within or without the State of Delaware, at such places as may be from time to time designated by the By-Laws or by resolution of the stockholders or Directors. Elections of Directors need not be by ballot unless the By-Laws of the Corporation shall so provide.

ELEVENTH:    The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute, and all rights conferred upon stockholders herein are granted subject to this reservation.

TWELFTH:    The name and address of the incorporator is Jeffrey A. Baumel, Esq. c/o McCarter & English, LLP, Four Gateway Center, 100 Mulberry Street, Newark, New Jersey 07102.

IN WITNESS WHEREOF, the undersigned, being the incorporator hereinabove named, does hereby execute this Certificate of Incorporation this 24^th day of November, 2003.

/s/ Jeffrey A. Baumel

Jeffrey A. Baumel, Esq.

Incorporator

- 3 -

AMENDMENT TO

THE

CERTIFICATE OF INCORPORATION

OF

AMERICAN CARESOURCE HOLDINGS, INC.

AMERICAN CARESOURCE HOLDINGS, INC., a corporation organized and existing by virtue of the General Corporation Law of the State of Delaware (the “Company”), pursuant to the provisions of the General Corporation Law of the State of Delaware (the “GCL”) DOES HEREBY CERTIFY as follows:

1. The following amendment to the Certificate of Incorporation herein certified has been duly adopted in accordance with the applicable provisions of Sections 228 and 242 of the GCL.

2. The certificate of the Company is hereby amended by striking out Article FOURTH thereof and by substituting in lieu of said Article FOURTH the following new Article:

FOURTH:(a) The total authorized capital stock of the Company shall be 50,000,000 shares, consisting of 40,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock which may be issued in one or more classes or series. The shares of Common Stock shall constitute a single class and shall be with $0.01 par value. The shares of Preferred Stock of each class or series shall be with $0.01 par value.

(b) Each holder of Common Stock, shall be entitled to one vote for each share of Common Stock held of record by such holder on all matters on which stockholders generally are entitled to vote; provided, however, that, except as otherwise required by law, holders of Common Stock, shall not be entitled to vote on any amendment to this Certificate of Incorporation (including any Certificate of Designations relating to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to this Certificate of Incorporation (including any Certificate of Designations relating to any series of Preferred Stock) or pursuant to the GCL.

- 4 -

In a Certificate of Designation authorizing any class or series of Preferred Stock, the Board of Directors is expressly authorized to determine:

(1)The distinctive designation of the class or series and the number of shares which will constitute the class or series, which number may be increased or decreased (but not below the number of shares then outstanding in that class or above the total shares authorized herein) from time to time by action of the Board of Directors;

(2)The dividend rate on the shares of the class or series, whether dividends will be cumulative, and, if so, from what date or dates;

(3)The price or prices at which, and the terms and conditions on which, the shares of the class or series may be redeemed at the option of the Company;

(4)Whether or not the shares of the class or series will be entitled to the benefit of a retirement or sinking fund to be applied to the purchase or redemption of such shares and, if so entitled, the amount of such fund and the terms and provisions relative to the operation thereof;

- 5 -

(5)Whether or not the shares of the class or series will be convertible into, or exchangeable for, any other shares of stock of the Company or other securities, and if so convertible or exchangeable, the conversion price or prices, or the rates of exchange, and any adjustments thereof, at which such conversion or exchange may be made, and any other terms and conditions of such conversion or exchange;

(6)The rights of the shares of the class or series in the event of voluntary or involuntary liquidation, dissolution or winding up of the Company;

(7)Whether or not the shares of the class or series will have priority over, parity with, or be junior to the shares of any other class or series in any respect, whether or not the shares of the class or series will be entitled to the benefit of limitations restricting the issuance of shares of any other class or series having priority over or on parity with the shares of such class or series and whether or not the shares of the class or series are entitled to restrictions on the payment of dividends on, the making of other distributions in respect of, and the purchase or redemption of shares of any other class or series of Preferred Stock or Common Stock ranking junior to the shares of the class or series;

(8)Whether the class or series will have voting rights, in addition to any voting rights provided by law, and if so, the terms of such voting rights; and

(9)Any other preferences, qualifications, privileges, options and other relative or special rights and limitations of that class or series.

IN WITNESS WHEREOF, the Company has caused this Certificate of Amendment to be executed this 25^th day of May, 2005.

AMERICAN CARESOURCE HOLDINGS, INC.

/s/David Boone

Name: David Boone

Title: Chief Financial Officer

- 6 -

AMENDMENT TO

THE

CERTIFICATE OF INCORPORATION

OF

AMERICAN CARESOURCE HOLDINGS, INC.

AMERICAN CARESOURCE HOLDINGS, INC., a corporation organized and existing by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), pursuant to the provisions of the General Corporation Law of the State of Delaware (the “GCL”) DOES HEREBY CERTIFY as follows:

1.The Certificate of Incorporation is hereby amended by adding to Article FOURTH the following subparagraph (c):

Effective as of the date hereof (the “Effective Date”) each 1 share of Common Stock of the Corporation issued and outstanding immediately prior to the Effective Date (“Old Common Stock”) shall automatically be split, without any action on the part of the holder thereof, into 110,000 shares for 1 share of fully paid and nonassessable Common Stock of the Corporation (“New Common Stock”).

Following the Effective Date, each holder of Old Common Stock shall be entitled to receive upon surrender of such holder's certificate(s) representing Old Common Stock (whether one or more, “Old Certificates”) for cancellation pursuant to procedures adopted by the Corporation, a certificate(s) representing the number of whole shares of New Common Stock (whether one or more, “New Certificates”) into which and for which the shares of Old Common Stock formerly represented by such Old Certificates so surrendered are reclassified under the terms hereof. From and after the Effective Date, Old Certificates shall represent only the right to receive New Certificates.

2.The preceding amendment to the Certificate of Incorporation herein certified has been duly adopted in accordance with the applicable provisions of Sections 228 and 242 of the GCL.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly executed in its corporate name on this 2^nd day of June, 2005.

AMERICAN CARESOURCE HOLDINGS, INC. 

By:/s/ David Boone

Name: David Boone

Title: Chief Financial Officer

- 7 -

AMENDMENT TO

THE

CERTIFICATE OF INCORPORATION

OF

AMERICAN CARESOURCE HOLDINGS, INC.

AMERICAN CARESOURCE HOLDINGS, INC., a corporation organized and existing by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), pursuant to the provisions of the General Corporation Law of the State of Delaware (the “GCL”)

DOES HEREBY CERTIFY as follows:

1.The Certificate of Incorporation is hereby amended by deleting Article FOURTH subparagraph (c) in its entirety and substituting in lieu thereof the following:

Effective as of the date hereof (the “Effective Date”) each 1 share of Common Stock of the Corporation issued and outstanding immediately prior to the Effective Date (“Old Common Stock”) shall automatically be split, without any action on the part of the holder thereof, into 1.1246645 shares for 1 share of fully paid and nonassessable Common Stock of the Corporation (“New Common Stock”).

Following the Effective Date, each holder of Old Common Stock shall be entitled to receive upon surrender of such holder's certificate(s) representing Old Common Stock (whether one or more, “Old Certificates”) for cancellation pursuant to procedures adopted by the Corporation, a certificate(s) representing the number of whole shares of New Common Stock (whether one or more, “New Certificates”) into which and for which the shares of Old Common Stock formerly represented by such Old Certificates so surrendered are reclassified under the terms hereof. From and after the Effective Date, Old Certificates shall represent only the right to receive New Certificates.

2The preceding amendment to the Certificate of Incorporation herein certified has been duly adopted in accordance with the applicable provisions of Sections 228 and 242 of the GCL.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly executed in its corporate name on this 14^th day of November, 2005.

AMERICAN CARESOURCE HOLDINGS, INC.

By:/s/ David Boone

Name: David Boone

Title: Chief Financial Officer

- 8 -

CERTIFICATE OF AMENDMENT

TO

CERTIFICATE OF INCORPORATION

OF

AMERICAN CARESOURCE HOLDINGS, INC.

American CareSource Holdings, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:

FIRST: That, by unanimous written consent in lieu of a meeting of the Board of Directors (the “Board”) of American CareSource Holdings, Inc. (the “Corporation”), resolutions were duly adopted setting forth a proposed amendment to the Certificate of Incorporation of the Corporation approving of a reverse stock split on a 1 for 2, 1 for 2.5, 1 for 3, 1 for 3.5 or 1 for 4 basis, as determined at the sole discretion of the Board (the “Reverse Split”), and, declaring said amendment (hereinafter the “Amendment”), to be advisable and calling for a meeting of the stockholders of the Corporation for consideration thereof. The resolution setting forth the proposed Amendment is substantially as follows:

RESOLVED, that the Certificate of Incorporation of the Corporation be amended by amending and restating Article FOURTH thereof relating to the authorized shares of the Corporation, so that, as amended, said Article FOURTH shall be and read in its entirety, as follows:

- 9 -

ARTICLE FOURTH

CAPITAL STOCK

On September 4, 2012, at 9:30 a.m. Eastern Daylight Time (the “Effective Time”), each three (3) shares of outstanding common stock, par value $0.01 per share (for purposes of this Article FOURTH “Old Common Stock”), of the Corporation issued and outstanding immediately prior to the Effective Time shall be, without any action of the holder thereof, automatically combined into one (1) validly issued, fully paid and non-assessable share of common stock, par value $0.01 per share (for purposes of this Article FOURTH, the “New Common Stock”) of the Corporation; such combination hereinafter referred to as the “Reverse Split.” Each stock certificate that, immediately prior to the Effective Time, represented shares of Old Common Stock shall, from and after the Effective Time, automatically and without the necessity of presenting the same for exchange, represent that number of whole shares of New Common Stock into which the shares of Old Common Stock represented by such certificate shall have been combined. No fractional shares of Common Stock will be issued as a result of the Reverse Split. In the event the Reverse Split leaves a stockholder with a fraction of a share, the stockholder would receive cash in lieu of such fractional share in an amount equal to the product obtained by multiplying (i) the closing sale price of the Corporation’s Old Common Stock on the business day immediately preceding the Effective Time as reported on the The Nasdaq Capital Market® by (ii) the number of shares of Old Common Stock held by the stockholder that would otherwise have been exchanged for the fractional share interest. For example, if the Reverse Split leaves an individual stockholder with one and one half shares, the stockholder would be issued, post Reverse Split, one whole share, and would receive cash in lieu of the remaining half share.

(a) The total authorized capital stock of the Company shall be 50,000,000 shares, consisting of 40,000,000 shares of Common Stock and 10,000,000 shares of Preferred Stock which may be issued in one or more classes or series. The shares of Common Stock shall constitute a single class and shall be with $0.01 par value. The shares of Preferred Stock of each class or series shall be with $0.01 par value.

(b) Each holder of Common Stock, shall be entitled to one vote for each share of Common Stock held of record by such holder on all matters on which stockholders generally are entitled to vote; provided, however, that, except as otherwise required by law, holders of Common Stock, shall not be entitled to vote on any amendment to this Certificate of Incorporation (including any Certificate of Designations relating to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to this Certificate of Incorporation (including any Certificate of Designations relating to any series of Preferred Stock) or pursuant to the GCL.

In a Certificate of Designation authorizing any class or series of Preferred Stock, the Board of Directors is expressly authorized to determine:

(1) The distinctive designation of the class or series and the number of shares which will constitute the class or series, which number may be increased or decreased (but not below the number of shares then outstanding in that class or above the total shares authorized herein) from time to time by action of the Board of Directors;

- 10 -

(2) The dividend rate on the shares of the class or series, whether dividends will be cumulative, and, if so, from what date or dates;

(3) The price or prices at which, and the terms and conditions on which, the shares of the class or series may be redeemed at the option of the Company;

(4) Whether or not the shares of the class or series will be entitled to the benefit of a retirement or sinking fund to be applied to the purchase or redemption of such shares and, if so entitled, the amount of such fund and the terms and provisions relative to the operation thereof;

(5) Whether or not the shares of the class or series will be convertible into, or exchangeable for, any other shares of stock of the Company or other securities, and if so convertible or exchangeable, the conversion price or prices, or the rates of exchange, and any adjustments thereof, at which such conversion or exchange may be made, and any other terms and conditions of such conversion or exchange;

(6) The rights of the shares of the class or series in the event of voluntary or involuntary liquidation, dissolution or winding up of the Company;

(7) Whether or not the shares of the class or series will have priority over, parity with, or be junior to the shares of any other class or series in any respect, whether or not the shares of the class or series will be entitled to the benefit of limitations restricting the issuance of shares of any other class or series having priority over or on parity with the shares of such class or series and whether or not the shares of the class or series are entitled to restrictions on the payment of dividends on, the making of other distributions in respect of, and the purchase or redemption of shares of any other class or series of Preferred Stock or Common Stock ranking junior to the shares of the class or series;

(8) Whether the class or series will have voting rights, in addition to any voting rights provided by law, and if so, the terms of such voting rights; and

(9) Any other preferences, qualifications, privileges, options and other relative or special rights and limitations of that class or series.”

- 11 -

SECOND: That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the holders of Common Stock of the Corporation was duly called and held upon notice in accordance with section 222 of the General Corporation Law of the State of Delaware, pursuant to which a majority of each class of stockholders voted in favor of the Amendment.

THIRD: That said Amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

IN WITNESS WHEREOF, the undersigned has executed this Certificate of Amendment to the Certificate of Incorporation of American CareSource Holdings, Inc. as of August 31, 2012.

AMERICAN CARESOURCE HOLDINGS, INC.

By: /s/ Kenn S. George

Name: Kenn S. George

Title: Chief Executive Officer and Chairman of the Board of Directors

- 12 -

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Kenneth S. George, certify that:

1. I have reviewed this quarterly report on Form 10-Q of American CareSource Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation, and

d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Dated:	November 9, 2012	By: /s/ Kenneth S. George
		Kenneth S. George
		Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Matthew D. Thompson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of American CareSource Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation, and

d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Dated:	November 9, 2012	By: /s/ Matthew D. Thompson
		Matthew D. Thompson
		Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Kenneth S. George, Chief Executive Officer of  American CareSource Holdings, Inc., (the “Company”) and Matthew D. Thompson, Chief Financial Officer of the Company, each certify pursuant to section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

1. The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2012, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	November 9, 2012	By: /s/ Kenneth S. George
		Kenneth S. George
		Chief Executive Officer
Dated:	November 9, 2012	By: /s/ Matthew D. Thompson
		Matthew D. Thompson
		Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to American CareSource Holdings, Inc. and will be retained by American CareSource Holdings, Inc. and furnished to the Securities and Exchange Commission upon request.

XML

Reverse Stock Split

9 Months Ended

Sep. 30, 2012

Reverse Stock Split [Abstract]

Reverse Stock Split

Reverse Stock Split

On August 31, 2012 the Company filed a Certificate of Amendment to its Certificate of Incorporation, as amended (the “Amendment”) to effect a 1-for-3 reverse stock split (“reverse split”) of its common stock, par value $0.01 per share (the “Common Stock”), effective September 4, 2012 (the “Effective Day”). Because the Amendment did not result in a reduction in the number of authorized shares of Common Stock, its effect was to increase the number of shares of Common Stock available for issuance relative to the number of shares issued and outstanding. In addition, the par value per share of Common Stock remained $0.01, thus Common Stock and Additional Paid-In Capital were adjusted $114,000 to reflect the reverse split on the consolidated balance sheet.

At the Company's annual meeting of stockholders, held on June 11, 2012, the stockholders voted to amend the Company's certificate of incorporation for the purpose of effecting a reverse stock split and authorized its Board of Directors to determine, in its sole discretion, whether to effect the amendment, the timing of the amendment, and the specific ratio of the reverse stock split, provided that such ratio is 1-for-2, 1-for-2.5, 1-for-3, 1-for-3.5 or 1-for-4.

On the Effective Day, every three shares of the Company's Common Stock issued and outstanding immediately prior to the Effective Day were automatically combined into one share of Common Stock. Stockholders that were left with a fraction of a share as a result of the reverse split received cash in lieu of the fractional share in an amount based on the closing sale price of the Common Stock on the business day immediately preceding the Effective Day as reported on the The Nasdaq Capital Market. The amount paid to stockholders was less than $1,000. In addition, any options, warrants and restricted stock units outstanding as of the Effective Day were adjusted accordingly. As a result of the reverse split, the Company had 5,706,443 shares of common stock issued and outstanding as of September 30, 2012.

Shares of common stock and common stock equivalents, along with earnings per share and other per share amounts, have been retroactively restated to reflect the 1-for-3 reverse stock split that occurred on September 4, 2012 for all periods presented.

XML

Revenue Recognition

9 Months Ended

Sep. 30, 2012

Revenue Recognition [Abstract]

Revenue Recognition

Revenue Recognition

The Company recognizes revenue on the services that it provides, which includes (i) providing payor clients with a comprehensive network of ancillary healthcare providers, (ii) providing claims management, reporting, processing and payment services, (iii) providing network/need analysis to assess the benefits to payor clients of adding additional/different service providers to the client-specific provider networks and (iv) providing credentialing of network service providers for inclusion in the client payor-specific provider networks.  Revenue is recognized when services are delivered, which occurs after processed claims are billed to the client payors and collections are reasonably assured.  The Company estimates revenues and costs of revenues using average historical collection rates and average historical margins earned on claims.  Periodically, revenues are adjusted to reflect actual cash collections so that revenues recognized accurately reflect cash collected.

The Company determines whether it is acting as a principal or agent in the fulfillment of the services rendered.  After careful evaluation of the key gross and net revenue recognition indicators, the Company acknowledges that while the determination of gross versus net reporting is highly judgmental in nature, the Company has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting.

Following are the key indicators that support the Company’s conclusion that it acts as a principal when settling claims for service providers through its contracted service provider network:

• The Company is the primary obligor in the arrangement.  The Company has assessed its role as primary obligor as a strong indicator of gross reporting.  The Company believes that it is the primary obligor in its transactions because it is responsible for providing the services desired by its client payors.  The Company has distinct, separately negotiated contractual relationships with its client payors and with the ancillary healthcare providers in its networks.  The Company does not negotiate “on behalf of” its client payors and does not hold itself out as the agent of the client payors when negotiating the terms of the Company’s ancillary healthcare service provider agreements.  The Company’s agreements contractually prohibit client payors and service providers to enter into direct contractual relationships with one another.  The client payors have no control over the terms of the Company’s agreements with the service providers.  In executing transactions, the Company assumes key performance-related risks.  The client payors hold the Company responsible for fulfillment, as the provider, of all of the services the client payors are entitled to under their contracts; client payors do not look to the service providers for fulfillment.  In addition, the Company bears the pricing/margin risk as the principal in the transactions.  Because the contracts with the client payors and service providers are separately negotiated, the Company has complete discretion in negotiating both the prices it charges its client payors and the financial terms of its agreements with the service providers.  Since the Company’s profit is the spread between the amounts received from the client payors and the amount paid to the service providers, it bears significant pricing/margin risk.  There is no guaranteed mark-up payable to the Company on the amount the Company has contracted.  Thus, the Company bears the risk that amounts paid to the service provider will be greater than the amounts received from the client payors, resulting in a loss or negative claim.

• The Company has latitude in establishing pricing.  As stated above, the Company has complete latitude in negotiating the price to be paid to the Company by each client payor and the price to be paid to each contracted service provider.  This type of pricing latitude indicates that the Company has the risks and rewards normally attributed to a principal in the transactions.

• The Company changes the product or performs part of the services.  The Company provides the benefits associated with the relationships it builds with the client payors and the service providers.  While the parties could deal with each other directly, the client payors would not have the benefit of the Company’s experience and expertise in assembling a comprehensive network of service providers, in claims management, reporting and processing and payment services, in performing network/needs analysis to assess the benefits to client payors of adding additional/different service providers to the client payor-specific provider networks, and in credentialing network service providers.

• The Company has complete discretion in supplier selection.  One of the key factors considered by client payors who engage the Company is to have the Company undertake the responsibility for identifying, qualifying, contracting with and managing the relationships with the ancillary healthcare service providers.  As part of the contractual arrangement between the Company and its client payors, the payors identify their obligations to their respective covered persons and then work with the Company to determine the types of ancillary healthcare services required in order for the payors to meet their obligations.  The Company may select the providers and contract with them to provide services at its discretion.

• The Company is involved in the determination of product or service specifications.  The Company works with its client payors to determine the types of ancillary healthcare services required in order for the payors to meet their obligations to their respective covered persons.  In some respects, the Company is customizing the product through its efforts and ability to assemble a comprehensive network of providers for its payors that is tailored to each payor’s specific needs.  In addition, as part of its claims processing and payment services, the Company works with the client payors, on the one hand, and the providers, on the other, to set claims review, management and payment specifications.

• The supplier (and not the Company) has credit risk.  The Company believes it has some level of credit risk, but that risk is mitigated because the Company does not remit payment to providers unless and until it has received payment from the relevant client payors following the Company’s processing of a claim.

• The amount that the Company earns is not fixed.  The Company does not earn a fixed amount per transaction nor does it realize a per-person per-month charge for its services.

The Company has evaluated the other indicators of gross and net revenue recognition, including whether or not the Company has general inventory risk.  The Company does not have any general inventory risk, as its business is not related to the manufacture, purchase or delivery of goods and it does not purchase in advance any of the services to be provided by the ancillary healthcare service providers.  While the absence of this risk would be one indicator in support of net revenue reporting, as described in detail above, the Company has carefully evaluated all of the key gross and net revenue recognition indicators and has concluded that its circumstances are most consistent with those key indicators that support gross revenue reporting.

If the Company were to report its revenues net of provider payments rather than on a gross reporting basis, for the three and nine months ended September 30, 2012, its net revenues would have been approximately $2.1 million and $6.8 million, respectively. For the three and nine months ended September 30, 2011, its net revenues would have been approximately $2.4 million and $8.2 million, respectively.

The Company records a provision for refunds based on an estimate of historical refund amounts. Refunds are paid to payors for overpayments on claims, claims paid in error, and claims paid for non-covered services. In some instances, we will recoup payments made to the ancillary service provider if the claim has been fully resolved. The evaluation is performed periodically and is based on historical data. We present revenue net of the provision for refunds on the consolidated statement of operations.

During the three and nine months ended September 30, 2012 and 2011, two of the Company’s clients, identified in the Company's annual report on Form 10-K for the year ended December 31, 2011, comprised a significant portion of the Company’s revenues.  The following is a summary of the approximate amounts of the Company’s revenue and accounts receivable contributed by each of those clients as of the dates and for the periods presented (amounts in thousands):

				Periods ended September 30, 2012													Periods ended September 30, 2011
	As of September 30, 2012			Three months					Nine Months					As of September 30, 2011			Three months					Nine Months
	Accounts Receivable			Net Revenue			% of Total Revenue		Net Revenue			% of Total Revenue		Accounts Receivable			Net Revenue			% of Total Revenue		Net Revenue			% of Total Revenue
Material Client Relationship	$	814		$	2,508		31	%	$	8,461		33	%	$	1,627		$	3,964		34	%	$	12,142		34	%
MultiPlan, Inc. (formerly Viant Holdings, Inc.)	200			706			9		2,412			9		756			2,535			22		7,794			22
All Others	1,841			5,049			61		15,117			59		1,556			5,130			45		16,382			45
Allowance for Uncollectable Receivables/Provision for refunds	(235		)	(77		)	(1	)	(188		)	(1	)	(159		)	(133		)	(1	)	(437		)	(1	)
	$	2,620		$	8,186		100	%	$	25,802		100	%	$	3,780		$	11,496		100	%	35,881			100	%

XML

Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net revenues	$ 8,186	$ 11,496	$ 25,802	$ 35,881
Cost of revenues
Provider payments	6,119	9,091	18,992	27,715
Administrative fees	340	616	1,168	1,791
Claims administration and provider development	922	1,067	2,865	3,446
Total cost of revenues	7,381	10,774	23,025	32,952
Contribution margin	805	722	2,777	2,929
Selling, general and administrative expenses	1,654	1,711	4,549	4,726
Goodwill impairment charge	0	4,361	0	4,361
Depreciation and amortization	222	204	662	585
Total operating expenses	1,876	6,276	5,211	9,672
Loss before income taxes	(1,071)	(5,554)	(2,434)	(6,743)
Income tax provision	4	969	28	647
Net loss	$ (1,075)	$ (6,523)	$ (2,462)	$ (7,390)
Loss per basic and diluted common share	$ (0.19)	$ (1.15)	$ (0.43)	$ (1.31)
Basic and diluted weighted average common shares outstanding	5,711	5,670	5,706	5,659

XML

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net loss	$ (2,462)	$ (7,390)
Adjustments to reconcile net loss to net cash used in operations:
Non-cash stock-based compensation expense	333	632
Depreciation and amortization	662	585
Goodwill impairment charge	0	4,361
Amortization of long-term client agreement	187	187
Client administration fee expense related to warrants	0	67
Deferred income taxes	3	615
Changes in operating assets and liabilities:
Accounts receivable	1,697	1,730
Prepaid expenses and other assets	0	(81)
Accounts payable and accrued liabilities	73	76
Due to service providers	(1,103)	(3,662)
Net cash used in operating activities	(610)	(2,880)
Cash flows from investing activities:
Investment in software development costs	(302)	(513)
Additions to property and equipment	(100)	(58)
Net cash used in investing activities	(402)	(571)
Cash flows from financing activities:
Payments of income tax withholdings on net exercise of equity incentives	(8)	0
Net cash used in financing activities	(8)	0
Net decrease in cash and cash equivalents	(1,020)	(3,451)
Cash and cash equivalents at beginning of period	11,315	14,512
Cash and cash equivalents at end of period	10,295	11,061
Supplemental cash flow information:
Cash paid for taxes	49	65
Supplemental non-cash operating and financing activity:
Income tax withholdings on conversion of equity incentives	0	37
Accrued bonus paid with equity incentives	$ 23	$ 0

XML

Description of Business and Basis of Presentation

9 Months Ended

Sep. 30, 2012

Description of Business and Basis of Presentation [Abstract]

Description of Business and Basis of Presentation

Description of Business and Basis of Presentation

American CareSource Holdings, Inc. (“ACS,” “Company,” the “Registrant,” “we,” “us,” or “our”) is an ancillary services company that offers cost effective access to a comprehensive national network of ancillary healthcare service providers.  The Company sells its services to a number of healthcare companies including preferred provider organizations ("PPOs"), third party administrators (“TPAs”), insurance companies, large self-funded organizations, various employee groups and other middle-market organizations.  The Company offers payors this solution by:

• lowering its payors’ ancillary care costs throughout its network of high quality, cost effective providers that the Company has under contract at more favorable terms than they could generally obtain on their own;

• providing payors with a comprehensive network of ancillary healthcare service providers that is tailored to each payor’s specific needs and is available to each payor’s covered persons for covered services;

• providing payors with claims management, reporting and processing and payment services;

• performing network/needs analysis to assess the benefits to payors of adding additional/different service providers to the payor-specific provider networks; and

• credentialing network service providers for inclusion in the payor-specific provider networks.  

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), interim reporting requirements of Form 10-Q and Rule 8-03 of Regulation S-X of the rules and regulations of the Securities and Exchange Commission (“SEC”).  Consequently, financial information and disclosures normally included in financial statements prepared annually in accordance with GAAP have been condensed or omitted.  Balance sheet amounts are as of September 30, 2012 and December 31, 2011 and operating results are for the three and nine months ended September 30, 2012 and 2011, and include all normal and recurring adjustments we consider necessary for the fair, summarized presentation of our financial position and operating results.  As these are condensed financial statements, readers of this report should, therefore, refer to the consolidated financial statements and the notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, filed with the SEC on March 9, 2012.

The Company uses the “management approach” for reporting information about segments in annual and interim financial statements.  The management approach is based on the way the chief operating decision-maker organizes segments within a company for making operating decisions and assessing performance.  Reportable segments are based on products and services, geography, legal structure, management structure and any other manner in which management disaggregates a company.  Based on the “management approach” model, the Company has determined that its business is comprised of a single operating segment.

Our interim results of operations are not necessarily indicative of results of operations that will be realized for the full fiscal year.

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 10,295	$ 11,315
Accounts receivable, net	2,620	4,317
Prepaid expenses and other current assets	381	559
Deferred income taxes	6	6
Total current assets	13,302	16,197
Property and equipment, net	1,665	1,829
Other assets:
Deferred income taxes	223	226
Other non-current assets	16	16
Intangible assets, net	800	896
Total assets	16,006	19,164
Current liabilities:
Due to service providers	2,575	3,678
Accounts payable and accrued liabilities	1,288	1,237
Total current liabilities	3,863	4,915
Commitments and contingencies
Shareholders' equity:
Preferred stock, $0.01 par value; 10,000 shares authorized, none issued	0	0
Common stock, $0.01 par value; 40,000 shares authorized; 5,706 and 5,692 shares issued and outstanding in 2012 and 2011, respectively	57	57
Additional paid-in capital	22,770	22,414
Accumulated deficit	(10,684)	(8,222)
Total stockholders' equity	12,143	14,249
Total liabilities and stockholders' equity	$ 16,006	$ 19,164

XML

Reverse Stock Split (Details) (USD $)	0 Months Ended	9 Months Ended			0 Months Ended
	Sep. 04, 2012	Sep. 30, 2012	Dec. 31, 2011	Sep. 04, 2012 Maximum	Jun. 11, 2012 Scenario 1	Jun. 11, 2012 Scenario 2	Jun. 11, 2012 Scenario 3	Jun. 11, 2012 Scenario 4	Jun. 11, 2012 Scenario 5	Sep. 30, 2012 Immediately prior to reverse split	Sep. 30, 2012 Immediately after reverse split
Class of Stock [Line Items]
Reverse stock split conversion ratio	0.3333				0.5000	0.4000	0.3333	0.2857	0.2500
Common stock, par value (in dollars per share)		$ 0.01	$ 0.01							$ 0.01	$ 0.01
Common Stock and Additional Paid-In Capital adjustment to reflect reverse split		$ 114,000
Common Stock, shares outstanding		5,706,443	5,691,562
Aggregate amount paid to stockholders				$ 1,000

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2012	Nov. 05, 2012
Entity Information [Line Items]
Entity Registrant Name	American Caresource Holdings, Inc.
Entity Central Index Key	0001316645
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Document Type	10-Q
Document Period End Date	Sep. 30, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		5,706,443

XML

Earnings (Loss) Per Share (Details)	3 Months Ended	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2012
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares excluded from calculation of earnings per share	730,000	730,000
Stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares excluded from calculation of earnings per share	119,445	119,445
Restricted Stock Units (RSU's)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares excluded from calculation of earnings per share	3,000	3,000

XML

Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2012	Dec. 31, 2011
Shareholders' equity:
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	5,706,443	5,691,562
Common Stock, shares outstanding	5,706,443	5,691,562

XML

Warrants

9 Months Ended

Sep. 30, 2012

Warrants [Abstract]

Warrants

Warrants

The Company entered into an agreement as of February 25, 2011 with an employee, whereby the Company agreed to issue warrants to purchase 83,333 shares of common stock with an exercise price of $5.01. The warrants have a term of 5 years and vest in increments over a time period of 2 years depending on the achievement of defined, agreed upon revenue targets generated by new clients. The agreement also obligates the Company to issue warrants to purchase up to an additional 166,666 shares of common stock (issued in 83,333 increments) pursuant to the achievement of additional defined agreed upon revenue targets. During the twelve months ended December 31, 2011, we did not recognize compensation costs associated with these warrants due to the low probability of vesting.

On February 1, 2012, certain terms of the agreement were modified, including the revenue targets and the total number of shares under the initial and future warrants. The warrants initially granted now cover 44,444 shares to be purchased at an exercise price of $1.50, 22,222 of which vested immediately, and the remaining 22,222 shares vesting upon the achievement of certain revenue targets. The number of shares underlying warrants to be issued under the agreement in the future was reduced to 88,889 shares (issued in 44,444 increments) based upon the achievement of additional defined agreed upon revenue targets.

During the nine months ended September 30, 2012, we recognized compensation costs of approximately $21,000 associated with the initial vesting of 22,222 shares. Additional costs associated with the warrants will be recognized based on the probability that the revenue targets will be reached. That probability will be re-evaluated and updated based on current market conditions, on a quarterly basis, and compensation costs will be adjusted accordingly.

Shares of common stock and exercise price have been restated to reflect the 1-for-3 reverse stock split that occurred on September 4, 2012.

XML

Software Development Costs

9 Months Ended

Sep. 30, 2012

Software Development Costs [Abstract]

Software Development Costs

Software Development Costs

The Company capitalizes costs associated with internally developed software, developed for internal use only, during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. Costs of significant upgrades and enhancements that result in additional functionality also are capitalized, whereas costs incurred for maintenance and minor upgrades and enhancements are expensed as incurred. Capitalized costs include external direct costs of materials and services utilized in developing or obtaining internal-use software and payroll and payroll-related expenses for employees who are directly associated with and devote time to the internal-use software projects. Capitalization of such costs begins when the preliminary project stage is complete and ceases no later than the point at which the project is substantially complete and ready for its intended purpose. Capitalized costs are amortized using the straight-line method over the useful life of the software, which is typically five years.

During the three and nine months ended September 30, 2012, the Company capitalized approximately $164,000 and $302,000, respectively. During the three and nine months ended September 30, 2011, the Company capitalized approximately $160,000 and $513,000, respectively.

XML

Software Development Costs (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Software Development Costs [Abstract]
Useful life of developed software			5 years
Capitalized software development costs	$ 164	$ 160	$ 302	$ 513

XML

Revenue Recognition (Net Provider Payments) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Revenue Recognition [Abstract]
Revenues, net of provider payments	$ 2.1	$ 2.4	$ 6.8	$ 8.2

XML

Subsequent Events

9 Months Ended

Sep. 30, 2012

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

We evaluate events and transactions that occur after the balance sheet date as potential subsequent events. No material event occurred subsequent to September 30, 2012.

XML

Revenue Recognition (Tables)

9 Months Ended

Sep. 30, 2012

Revenue Recognition [Abstract]

Summary of Revenues and Accounts Receivable Contributed by Client

The following is a summary of the approximate amounts of the Company’s revenue and accounts receivable contributed by each of those clients as of the dates and for the periods presented (amounts in thousands):

				Periods ended September 30, 2012													Periods ended September 30, 2011
	As of September 30, 2012			Three months					Nine Months					As of September 30, 2011			Three months					Nine Months
	Accounts Receivable			Net Revenue			% of Total Revenue		Net Revenue			% of Total Revenue		Accounts Receivable			Net Revenue			% of Total Revenue		Net Revenue			% of Total Revenue
Material Client Relationship	$	814		$	2,508		31	%	$	8,461		33	%	$	1,627		$	3,964		34	%	$	12,142		34	%
MultiPlan, Inc. (formerly Viant Holdings, Inc.)	200			706			9		2,412			9		756			2,535			22		7,794			22
All Others	1,841			5,049			61		15,117			59		1,556			5,130			45		16,382			45
Allowance for Uncollectable Receivables/Provision for refunds	(235		)	(77		)	(1	)	(188		)	(1	)	(159		)	(133		)	(1	)	(437		)	(1	)
	$	2,620		$	8,186		100	%	$	25,802		100	%	$	3,780		$	11,496		100	%	35,881			100	%

XML

Revenue Recognition (Revenue and Accounts Receivable) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Concentration Risk [Line Items]
Allowance for Uncollectable Receivables	$ (235)	$ (159)	$ (235)	$ (159)
Accounts Receivable, Net	2,620	3,780	2,620	3,780	4,317
Provision for refunds	(77)	(133)	(188)	(437)
Revenue, Net	8,186	11,496	25,802	35,881
Sales Revenue
Concentration Risk [Line Items]
% of Total Revenue	100.00%	100.00%	100.00%	100.00%
Sales Revenue | Provision for refunds
Concentration Risk [Line Items]
% of Total Revenue	(1.00%)	(1.00%)	(1.00%)	(1.00%)
Customer Concentration Risk | Material Client Relationship
Concentration Risk [Line Items]
Accounts Receivable, Gross	814	1,627	814	1,627
Revenue, Gross	2,508	3,964	8,461	12,142
Customer Concentration Risk | MultiPlan, Inc.
Concentration Risk [Line Items]
Accounts Receivable, Gross	200	756	200	756
Revenue, Gross	706	2,535	2,412	7,794
Customer Concentration Risk | All Others
Concentration Risk [Line Items]
Accounts Receivable, Gross	1,841	1,556	1,841	1,556
Revenue, Gross	$ 5,049	$ 5,130	$ 15,117	$ 16,382
Customer Concentration Risk | Sales Revenue | Material Client Relationship
Concentration Risk [Line Items]
% of Total Revenue	31.00%	34.00%	33.00%	34.00%
Customer Concentration Risk | Sales Revenue | MultiPlan, Inc.
Concentration Risk [Line Items]
% of Total Revenue	9.00%	22.00%	9.00%	22.00%
Customer Concentration Risk | Sales Revenue | All Others
Concentration Risk [Line Items]
% of Total Revenue	61.00%	45.00%	59.00%	45.00%

XML

Consolidated Statement of Stockholders' Equity (USD $) In Thousands, except Share data, unless otherwise specified	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Balance at Dec. 31, 2011	$ 14,249	$ 57	$ 22,414	$ (8,222)
Balance, shares at Dec. 31, 2011	5,691,562	5,692,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,462)	0	0	(2,462)
Stock-based compensation expense	333	0	333	0
Issuance of common stock as equity incentive awards, net of tax withholdings	23	0	23	0
Issuance of common stock as equity incentive awards, net of tax withholdings, shares		13,000
Issuance of common stock upon conversion of restricted stock units, net of tax withholdings	0	0	0	0
Issuance of common stock upon conversion of restricted stock units, net of tax withholdings, shares		1,000
Balance at Sep. 30, 2012	$ 12,143	$ 57	$ 22,770	$ (10,684)
Balance, shares at Sep. 30, 2012	5,706,443	5,706,000

XML

Earnings (Loss) Per Share

9 Months Ended

Sep. 30, 2012

Earnings Per Share [Abstract]

Earnings (Loss) Per Share

Earnings (Loss) Per Share

For purposes of this calculation, outstanding stock options, stock warrants, and unvested restricted stock units are considered common stock equivalents using the treasury stock method, and are the only such equivalents outstanding.  For the three and nine months ended September 30, 2012, options to purchase approximately 730,000 shares of common stock, warrants to purchase 119,445 shares of common stock and approximately 3,000 unvested restricted stock units were excluded from the calculation as their impact would be anti-dilutive.

XML

Warrants (Details) (USD $)	0 Months Ended			9 Months Ended		0 Months Ended
	Sep. 04, 2012	Feb. 25, 2011	Feb. 01, 2012	Sep. 30, 2012 Vested immediately	Feb. 01, 2012 Vested immediately	Feb. 25, 2011 Vested upon acheivement of additional defined revenue targets	Feb. 01, 2012 Vested upon acheivement of additional defined revenue targets	Feb. 01, 2012 Acheivement of additional defined revenue targets	Feb. 25, 2011 Acheivement of additional defined revenue targets
Class of Warrant or Right [Line Items]
Reverse stock split conversion ratio	0.3333
Warrants issued		83,333	44,444		22,222		22,222	88,889	166,666
Exercise price		5.01	1.50
Award expiration period		5 years
Award vesting period						2 years
Incremental warrant issues								44,444	83,333
Compensation costs				$ 21,000